Korea Ginseng Corp. (JungKwanJang) Receives 'Tyler Award' from American Botanical Council

Korea Ginseng Corp. (JungKwanJang) Receives 'Tyler Award' from American Botanical Council

- The American Botanical Council (ABC) selects institutions that contribute to scientific research on natural products worldwide. CERRITOS, Calif., March 11, 2025 /PRNewswire/ -- Korea Ginseng Corp. (KGC), known for its flagship brand JungKwanJang,...

Celltrion receives U.S. FDA approval for STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo) biosimilars referencing PROLIA® and XGEVA®

Celltrion receives U.S. FDA approval for STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo) biosimilars referencing PROLIA® and XGEVA®

STOBOCLO® (denosumab-bmwo) and OSENVELT® (denosumab-bmwo) are approved by FDA for all indications of reference products PROLIA® (denosumab) and XGEVA® (denosumab) respectively[1], [2] The FDA approval is based on robust clinical evidence, which show...

So-Young Receives Approval to Transfer to Nasdaq Capital Market and Extension of Minimum Bid Price Compliance Period

So-Young Receives Approval to Transfer to Nasdaq Capital Market and Extension of Minimum Bid Price Compliance Period

BEIJING, Feb. 27, 2025 /PRNewswire/ -- So-Young International Inc. (NASDAQ: SY) ("So-Young" or the "Company"), the largest and most vibrant social community in China for consumers, professionals and service providers in the medical aesthetics...

ZEISS VISUMAX 800 with SMILE pro software receives approval in China

ZEISS VISUMAX 800 with SMILE pro software receives approval in China

Updated ZEISS femtosecond laser provides refractive surgeons in China with faster treatment, greater flexibility, and significant workflow JENA, Germany and SHANGHAI, Feb. 27, 2025 /PRNewswire/ -- ZEISS Medical Technology announced today that the...

MediBeacon® Transdermal GFR System receives device approval in China

MediBeacon® Transdermal GFR System receives device approval in China

Peer-reviewed articles on MediBeacon technology published Transdermal GFR System (TGFR) is a first-in-kind product for point of care assessment of kidney function in patients with normal or impaired renal function. The Clinical Kidney Journal in...

HKBU receives resounding support from Nobel Laureate and field experts in new medical school proposal and the establishment of translational medical research institute

HKBU receives resounding support from Nobel Laureate and field experts in new medical school proposal and the establishment of translational medical research institute

HONG KONG, Feb. 24, 2025 /PRNewswire/ -- The Preparatory Committee and Expert Advisory Committee for the New Medical School set up by Hong Kong Baptist University (HKBU) held a meeting yesterday (23 February), during which progress of the...

Global Education Leader Recognised: Trio Schools' Managing Director receives prestigious BW Education 40 Under 40 award for educational innovation in India

Global Education Leader Recognised: Trio Schools' Managing Director receives prestigious BW Education 40 Under 40 award for educational innovation in India

BENGALURU, India, Feb. 21, 2025 /PRNewswire/ -- Trio Schools' Managing Director, Mr. Naveen KM has been honoured with the prestigious BW Education 40 under 40 award, in association with Business World, for his contributions to the field of...

NAVER D2SF-Backed PranaQ® Receives FDA 510(k) Clearance for TipTraQ, an AI-Enabled Home Sleep Apnea Test

NAVER D2SF-Backed PranaQ® Receives FDA 510(k) Clearance for TipTraQ, an AI-Enabled Home Sleep Apnea Test

SEOUL, South Korea, Feb. 21, 2025 /PRNewswire/ -- PranaQ, backed by NAVER D2SF continues to push the boundaries of AI-powered healthcare solutions. NAVER D2SF, NAVER's corporate venturing arm, actively collaborates with startups to drive innovation...

Clarity receives US FDA Fast Track Designation for the treatment of metastatic castration-resistant prostate cancer patients with Cu-67 SAR-bisPSMA

Clarity receives US FDA Fast Track Designation for the treatment of metastatic castration-resistant prostate cancer patients with Cu-67 SAR-bisPSMA

SYDNEY, Feb. 19, 2025 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for children and...

Innovent Receives Second Fast Track Designation from the U.S. FDA for IBI363 (PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) in Squamous Non-Small Cell Lung Cancer

Innovent Receives Second Fast Track Designation from the U.S. FDA for IBI363 (PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) in Squamous Non-Small Cell Lung Cancer

SAN FRANCISCO and SUZHOU, China, Feb. 17, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of...

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • menu
    menu